Literature DB >> 32022655

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2020        PMID： 32022655      PMCID： PMC7012085          DOI： 10.1080/21645515.2020.1704575

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  6 in total

1.  A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer.

Authors:  Shuangshuang Lu; Zhe Zhang; Pan Du; Louisa S Chard; Wenli Yan; Margueritte El Khouri; Zhizhong Wang; Zhongxian Zhang; Yongchao Chu; Dongling Gao; Qinxian Zhang; Lirong Zhang; Ai Nagano; Jun Wang; Claude Chelala; Jing Liu; Jiekai Chen; Pentao Liu; Yunshu Dong; Shengdian Wang; Xiaozhu Li; Jianzeng Dong; Nick R Lemoine; Duanqing Pei; Yaohe Wang
Journal:  Clin Cancer Res       Date:  2019-11-25       Impact factor: 12.531

2.  Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.

Authors:  Emmanuel S Antonarakis; Josep M Piulats; Marine Gross-Goupil; Jeffrey Goh; Kristiina Ojamaa; Christopher J Hoimes; Ulka Vaishampayan; Ranaan Berger; Ahmet Sezer; Tuomo Alanko; Ronald de Wit; Chunde Li; Aurelius Omlin; Giuseppe Procopio; Satoshi Fukasawa; Ken-Ichi Tabata; Se Hoon Park; Susan Feyerabend; Charles G Drake; Haiyan Wu; Ping Qiu; Jeri Kim; Christian Poehlein; Johann Sebastian de Bono
Journal:  J Clin Oncol       Date:  2019-11-27       Impact factor: 44.544

3.  Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.

Authors:  Shibadas Biswal; Humberto Reynales; Xavier Saez-Llorens; Pio Lopez; Charissa Borja-Tabora; Pope Kosalaraksa; Chukiat Sirivichayakul; Veerachai Watanaveeradej; Luis Rivera; Felix Espinoza; LakKumar Fernando; Reynaldo Dietze; Kleber Luz; Rivaldo Venâncio da Cunha; José Jimeno; Eduardo López-Medina; Astrid Borkowski; Manja Brose; Martina Rauscher; Inge LeFevre; Svetlana Bizjajeva; Lulu Bravo; Derek Wallace
Journal:  N Engl J Med       Date:  2019-11-06       Impact factor: 91.245

4.  Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.

Authors:  Phillip R Pittman; Matthew Hahn; HeeChoon S Lee; Craig Koca; Nathaly Samy; Darja Schmidt; Joachim Hornung; Heinz Weidenthaler; Christopher R Heery; Thomas P H Meyer; Günter Silbernagl; Jane Maclennan; Paul Chaplin
Journal:  N Engl J Med       Date:  2019-11-14       Impact factor: 91.245

5.  Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer.

Authors:  Mohammadhadi Khorrami; Prateek Prasanna; Amit Gupta; Pradnya Patil; Priya D Velu; Rajat Thawani; German Corredor; Mehdi Alilou; Kaustav Bera; Pingfu Fu; Michael Feldman; Vamsidhar Velcheti; Anant Madabhushi
Journal:  Cancer Immunol Res       Date:  2019-11-12       Impact factor: 11.151

6.  Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.

Authors:  Barbara Burtness; Kevin J Harrington; Richard Greil; Denis Soulières; Makoto Tahara; Gilberto de Castro; Amanda Psyrri; Neus Basté; Prakash Neupane; Åse Bratland; Thorsten Fuereder; Brett G M Hughes; Ricard Mesía; Nuttapong Ngamphaiboon; Tamara Rordorf; Wan Zamaniah Wan Ishak; Ruey-Long Hong; René González Mendoza; Ananya Roy; Yayan Zhang; Burak Gumuscu; Jonathan D Cheng; Fan Jin; Danny Rischin
Journal:  Lancet       Date:  2019-11-01       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.